Latest Submitted Abstracts

ISR Autumn Meeting 2018

TBA (18A109)

EFFECTS OF BARICITINIB ON PATIENTS WHO STOP METHOTREXATE MONOTHERAPY AND SWITCH TO BARICITINIB MONOTHERAPY

ISR Autumn Meeting 2018

TBA (18A108)

NSAIDs (Non Steroidal anti inflammatory drugs) prescription’s practice in Rheumatology Department

ISR Autumn Meeting 2018

TBA (18A107)

Rapid Response With Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs

ISR Autumn Meeting 2018

TBA (18A105)

Real Life Switching from Infliximab Innovator (Remicade) to Biosimilar (Inflectra) in Patients with Various Rheumatic Diseases: a 6-month Single-Centre Prospective Observational Study

ISR Autumn Meeting 2018

TBA (18A104)

The Utility and Limitations of CRP, ESR and DAS28-CRP, in Appraising Synovial Inflammation in Rheumatoid Arthritis

ISR Autumn Meeting 2018

TBA (18A101)

Monitoring of lipids in patients on tocilizumab following introduction of ‘new subcutaneous tocilizumab progress chart’

ISR Autumn Meeting 2017

TBA (17A174)

Joint Specific Transcriptional Programmes Regulate Inflammation in CD141+DC in Inflammatory Arthritis

ISR Autumn Meeting 2017

TBA (17A112)

Obesity predicts worse disease outcomes in axial spondyloarthropathy patients

ISR Autumn Meeting 2017

TBA (17A123)

A comparative study of lean muscle mass in patients with newly diagnosed Inflammatory Arthritis and established Inflammatory Arthritis

ISR Autumn Meeting 2017

TBA (17A161)

Is It Still Still’s?